Our legal experts track the evolving regulation around the CBD and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
17th March 2022
Australia: The Therapeutics Goods Administration (TGA) refuses to grant pets access to medical cannabis, press reports. The TGA decision follows a letter submitted by a veterinary centre (eCS Vet) that requested an amendment of the Poisons Standard so medical cannabis can be also prescribed for animal use. TGA in turn said that “the risks and toxicity of cannabinoid substances outweigh the potential benefit”.
17th March 2022
Australia: Therapeutic Goods Administration (TGA) president John Skerritt has said in an interview that products containing delta-8 THC are not legal in the country, press reports. Skerritt argued that the compound can be found naturally only in tiny amounts and it is illegal because it is chemically manufactured. He added that products containing delta-8 THC may be considered prohibited substances.
25th February 2022
Australia: The state of Victoria has announced an amendment to its schedule system that will allow doctors to prescribe cannabis without prior state authorisation, press reports. The change will facilitate patient access to cannabis. The amendment will come into effect on Monday 28th February.
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.